Six pharma companies reported to be under investigation for opioid shipments
Posted: 27 November 2019 | Victoria Rees (European Pharmaceutical Review) | No comments yet
US prosecutors have handed subpoenas to six pharmaceutical companies and distributors for their role in the opioid crisis, as reported.
Six pharmaceutical companies are under investigation from the US government as they potentially imported large quantities of opioids which contributed to the crisis in the country, reports Reuters.
According to the outlet, regulatory filings say five businesses have received subpoenas from Brooklyn federal prosecutors: Teva Pharmaceutical Industries Ltd, Mallinckrodt Plc, Johnson & Johnson, Amneal Pharmaceuticals Inc and distributor McKesson Corp.
The Wall Street Journal, which was first to report the investigation, also listed AmerisourceBergen Corp as having received a subpoena.
The report claims that several companies have admitted to receiving grand jury subpoenas, suggesting they are part of a criminal investigation.
Teva is reported to be confident in its supply chain, with its medicine imports delivered according to regulations.
Related topics
Distribution & Logistics, Drug Supply Chain, Legal, Research & Development (R&D)
Related organisations
AmerisourceBergen Corp, Amneal Pharmaceuticals Inc, Johnson & Johnson, Mallinckrodt Plc, McKesson Corp, Teva Pharmaceutical Industries Ltd
